New York, NYUSA
July 9, 2012
Affordable, clustered housing for biotech entrepreneurs and researchers (similar to the housing made available for people in the arts at Manhattan Towers on 42nd Street) so that social and professional interactions can be encouraged naturally. Also, the industry needs more angel investors willing to gamble on early stage drug development and diagnostic companies.
I am a founding member of the Mid Atlantic Bio Angels, an angel investor group consisting primarily of individuals with knowledge and experience in the life sciences industry. I am also a corporate partner at Pryor Cashman LLC, a NYC law firm.
First meeting. So far, so good.